Ab Index-Nr. 606-072-00-5

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
606-072-00-53-acetyl-1-phenyl-pyrrolidine-2,4-dione421-600-2719-86-8STOT RE 2 (*)
Aquatic Chronic 2
H373 (*)(*)
H411
GHS08
GHS09
Wng
H373 (*)(*)
H411
   
606-073-00-04,4'-bis(dimethylamino)benzo-
phenone;
Michler's ketone
202-027-590-94-8Carc. 1B
Muta. 2
Eye Dam. 1
H350
H341
H318
GHS08
GHS05
Dgr
H350
H341
H318
   
606-074-00-6reaction mass of: (1R*,2S*)-2-acetyl-
1,2,3,4,5,6,7,8-octahydro-
1,2,8,8-tetramethylnaphthalene;
(2R*,3S*)-2-acetyl--
1,2,3,4,5,6,7,8-octahydro-
2,3,8,8-tetramethylnaphthalene
425-570-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-075-00-11-benzyl-5-ethoxyimidazoli-
dine-2,4-dione
417-340-465855-02-9Acute Tox. 4 (*)H302GHS07
Wng
H302   
606-076-00-71-((2-quinolinyl-carbonyl)oxy)-
2,5-pyrrolidinedione
418-630-3136465-99-1Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
606-077-00-2(3S,4S)-3-hexyl-4-[(R)-2-
hydroxytridecyl]-2-
oxetanone
418-650-2104872-06-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-078-00-81-octylazepin-2-one420-040-659227-88-2Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
   
606-079-00-32-n-butyl-benzo[d]isothiazol-
3-one
420-590-74299-07-4Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
   
606-081-00-4(3β, 5α, 6β)-3-(ace­tyloxy)-5-bro­mo-6-hy­droxy-an­drostan-17-one419-790-74229-69-0Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
606-082-00-Xreaction mass of: butan-2-
one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7 STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H372 (*)(*)
H317
H412
GHS08
GHS07
Dgr
H372 (*)(*)
H317
H412
   
606-083-00-52-chloro-5-sec-hexadecylhy-
droquinone
407-750-1137193-60-3Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Wng
H319
H315
H317
H412
   
606-084-00-01-(4-methoxy-5-benzofuranyl)-
3-phenyl-1,3-propanedione
414-540-3484-33-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-085-00-6(1R,4S)-2-azabicy-
clo[2.2.1]hept-5-en-3-one
418-530-179200-56-9Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
   
606-086-00-11-(3,3-dimethylcyclohe-
xyl)pent-4-en-1-one
422-330-856973-87-6Aquatic Chronic 2H411GHS09H411   
606-087-00-76-ethyl-5-fluoro-4(3H)-pyrimi-
done
422-460-5137234-87-8Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
606-088-00-22,4,4,7-tetramethyl-6-octen-
3-one
422-520-074338-72-0Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
606-089-00-8reaction mass of: 1,4-diamino-2-chloro-3-
phenoxyanthraquinone;
1,4-diamino-2,3-bis-phe-
noxyanthraquinone
423-220-212223-77-7Aquatic Chronic 4H413H413   
606-090-00-31-[3-[(dimethylamino)methyl]-4-
hydroxyphenyl]ethanone
430-920-173096-98-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
606-091-00-96-chloro-5-(2-chloroethyl)-1,3-
dihydroindol-2-one
421-320-0118289-55-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-092-00-4reaction mass of: (E)-oxacyclohexadec-12-
en-2-one;
(E)-oxacyclohexadec-13-en-2-
one;
a)(Z)-oxacyclohexadec-(12)-en-
2-one and b)
(Z)-oxacyclohexadec-(13)-en-
2-one
422-320-3 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-093-00-X5-ethyl-2,4-dihydro-4-(2-
phenoxyethyl)-3H-1,2,4-triazol-
3-one
414-470-395885-13-5Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
606-094-00-5N-[ethyl(3-methylbutyl)amino]-
3-methyl-1-phenyl-spi-
ro[[1]benzo-pyrano[2,3-c]pyra-
zole-4(1H),1´(3´H)-isobenzo-
furan]-3´-one
417-460-7Aquatic Chronic 4H413H413   
606-095-00-0(R,S)-2-azabicyclo[2.2.1]
hept-5-en-3-one
421-830-349805-30-3Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
606-096-00-63-(6-O-(6-desoxy-α-l-
mannopyranosyl-O-(α-d-
glucopyranosyl)-(β-d-
glucopyranosyl)oxy)-2-(3,4-
dihydroxyphenyl)-5,7-dihy-
droxy-4H-1-benzopyran-4-one
424-170-4130603-71-3Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
606-097-00-12,2´´-dihydroxy-4,4´´-
(2-hydroxy-propane-1,3-
diyldioxy)dibenzophenone
424-210-023911-85-5Aquatic Chronic 4H413H413   
606-098-00-71-benzyl-5-(hexadecyloxy)-2,4-
imidazolidinedione
431-220-9158574-65-3Aquatic Chronic 4H413H413   
606-099-00-25-methoxy-4´-
(trifluoromethyl)valerophenone
425-000-161718-80-7Aquatic Chronic 2H411GHS09H411   
606-100-00-62-butyryl-3-hydroxy-5-
thiocyclohexan-3-yl-cyclohex-
2-en-1-one
425-150-894723-86-1Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H360F ***
H302
H317
H412
GHS08
GHS07
Dgr
H360F ***
H302
H317
H412
   
606-101-00-1reaction mass of: 1,5-bis[(2-
ethylhexyl)amino]-9,10-
anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-
ethylhexyl)oxy]propyl]amino-
9,10-anthracenedione;
1,5-bis[3-[(2-ethyl-
hexyl)oxy]propyl]amino-9,10-
anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-
methoxypropyl)amino]-9,10-
anthracene dione;
1-[3-[(2-ethylhexyl)oxy]pro-
pyl]amino-5-[(3-
methoxypropyl)amino]-9,10-
anthracenedione;
1,5-bis[(3-methyloxypropyl)ami-
no]-9,10-anthracenedione
426-050-7165038-51-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-102-00-74-(3-triethoxysilylpropoxy)-2-
hydroxybenzophenone
431-490-879876-59-8Aquatic Chronic 2H411GHS09H411   
606-103-00-21-(4-(trans-4-ethylcyclo-
hexyl)phenyl)ethanone
426-460-6Skin Sens. 1H317GHS07
Wng
H317   
606-104-00-81-(4-(trans-4-pentylcyclo-
hexyl)phenyl)ethanone
426-830-778531-59-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-105-00-33,4,3´,4´-tetraphenyl-1,1´-
ethandiylbispyrol-2,5-dione
431-500-0226065-73-2Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-106-00-91-(4-(trans-4-butylcyclo-
hexyl)phenyl)ethanone
427-320-783626-30-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-107-00-48-azaspiro[4.5]decane-7,9-
dione
427-770-41075-89-4Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
   
606-108-00-X1,1,1,2,2,4,5,5,5-nonafluoro-4-
(trifluoromethyl)-3-pentanone
436-710-6756-13-8Aquatic Chronic 3H412H412   
606-109-00-52-(4-methyl-3-
pentenyl)anthraquinone
428-320-171308-16-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H413
GHS07
Wng
H302
H317
H413
   
606-110-00-05-ethoxy-5H-furan-2-one428-330-42833-30-9Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H312
H302
H373 **
H317
GHS05
GHS08
GHS07
Dgr
H314
H312
H302
H373 **
H317
   
606-111-00-65-amino-6-methyl-1,3-
dihydrobenzoimidazol-2-one
428-410-967014-36-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
606-112-00-1(4aR*,8aR*)-4a,5,9,10,11,12-
hexahydro-3-methoxy-11-
methyl-6H-benzofuro[3a,3,2-
ef][2]benzazepin-6-one
428-690-21668-86-6Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
   
606-113-00-71-[4-(4-benzoylphenyl-
sulfanyl)phenyl]-2-methyl-2-
(4-methylphenylsulfonyl)pro-
pan-1-one
429-040-0272460-97-6Eye Dam. 1
Aquatic Chronic 4
H318
H413
GHS05
Dgr
H318
H413
   
606-114-00-24,4´,5,5´,6,6´,7,7´-octachloro-
(2,2´)biisoindolyl-1,1´,3,3´-
tetraone
429-150-967887-47-2Aquatic Chronic 4H413H413   
606-115-00-8profoxydim (ISO);
2-{(EZ)-1-[(2RS)-2-(4-
chlorophenoxy)propoxyimino]
butyl}-3-hydroxy-5-(thian-3-
yl)cyclohex-2-en-1-one
139001-49-3Carc. 2
Repr. 2
Skin Sens. 1
H351
H361d
H317
GHS08
GHS07
Wng
H351
H361d
H317
   
606-116-00-3tepraloxydim (ISO);
(RS)-(EZ)-2-{1-[(2E)-3-
chloroallyloxyimino]propyl}-3-
hydroxy-5-perhydropyran-4-
ylcyclohex-2-en-1-one
149979-41-9Carc. 2
Repr. 2
H351
H361fd
GHS08
Wng
H351
H361fd
   
606-117-00-92,6-bis(1,1-dimethylethyl)-4-
(phenylenemethylene)cyclo-
hexa-2,5-dien-1-one
429-460-47078-98-0Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-118-00-4N-(1,3-dimethylbutyl)-N´-(phe-
nyl)-1,4-benzoquinonediimine
429-640-252870-46-9Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
   
606-119-00-X(E)-3-methyl-5-cyclopenta-
decen-1-one
429-900-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
606-120-00-52,5-dihydroxy-5-methyl-3-
(morpholin-4-yl)-2-cyclopenten-
1-one
430-170-5114625-74-0Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
606-121-00-0(+)-(1S,2S,3S,5R)-2,6,6-
trimethylbicyclo[3.1.1]heptane-
3-spiro-1´-(cyclohex-2´-en-4´-
one)
430-460-1133636-82-5Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
   
606-122-00-63-(2-bromopropionoyl)-4,4-
dimethyl-1,3-oxazolan-2-one
430-820-8114341-88-7Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373 **
H315
H318
H317
H410
   
606-123-00-14-hexadecyl-1-phenylpyrazoli-
din-3-one
430-840-7Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-124-00-71-cyclopropyl-3-(2-methylthio-4-
trifluoromethylphenyl)-1,3-
propanedione
421-080-7161462-35-7STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
   
606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Acute Tox. 4 *H302GHS07
Wng
H302   
606-126-00-81,4-bis(2,3-dihydroxypropyl-
amino)anthraquinone
421-470-799788-75-7Aquatic Chronic 2H411GHS09H411   
606-128-00-92,2´-(1,3-phenylene)bis[5-
chloro-1H-isoindole]-1,3(2H)-
dione
422-650-8148935-94-8Aquatic Chronic 4H413H413   
606-129-00-45-amino-[2S-di(methyl-
phenyl)amino]-1,6-diphenyl-
4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzyl-
amino)-1,6-diphenylhex-4-en-
3-one
423-090-7156732-13-7Aquatic Chronic 4H413H413   
606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-
cyclohexanone
423-860-256309-94-5Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
606-131-00-5cyclic 3-(1,2-ethanediylacetale)-
estra-5(10),9(11)-diene-3,17-
dione
427-230-85571-36-8Repr. 1B
STOT RE 2 *
Aquatic Chronic 2
H360F ***
H373 **
H411
GHS08
GHS09
Dgr
H360F ***
H373 **
H411
   
606-132-00-0(6β)-6,19-epoxyandrost-
4-ene-3,17-dione
433-490-36563-83-3Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
606-134-00-1androsta-1,4,9(11)-triene-3,17-
dione
433-560-315375-21-0Repr. 2H361f ***GHS08
Wng
H361f ***   
606-135-00-7cyclohexadecanone438-930-82550-52-9Aquatic Chronic 4H413H413   
606-136-00-2(3S,6R,9S,12R,15S,18R,21S,
24R)-6,18-dibenzyl-3,9,15,21-
tetraisobutyl-4,10,12,16,22,24-
hexamethyl-1,7,13,19-tetraoxa-
4,10,16,22-tetraazacyclotetra-
cosane-2,5,8,11,14,17,20,23-
octaone
444-350-6133413-70-4Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
   
606-137-00-8trans-7,7´-dimethyl-(4H,4H´)-
(2,2´)bi[benzo[1,4]thiazinyli-
dene]-3,3´-dione
444-750-0211387-26-7Aquatic Chronic 4H413H413   
606-138-00-3(2-butyl-5-nitrobenzofuran-3-
yl)[4-(3-dibutylaminopro-
poxy)phenyl]methanone
444-800-1141645-23-0Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373 **
H315
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H226
H302
H373 **
H315
H318
H317
H410
 M = 10 
606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-
dihydro-2H-naphthalen-1-one
444-830-5124379-29-9Aquatic Chronic 4H413H413   
606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-
methylpropionyl)benzyl)phe-
nyl)-2-methylpropan-1-one
444-860-9474510-57-1STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
   
606-141-00-Xsodium 3-(methoxycarbo-
nyl)-4-oxo-3,4,5,6-tetrahy-
dro-2-pyridinolate
418-410-7Eye Irrit. 2H319GHS07
Wng
H319   
606-142-00-5reaction mass of:
(1RS,2SR,7SR,8SR,E) 9 and
10-ethylidene-3-oxatricy-
clo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-
ethylidene-3-oxatricy-
clo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-
ethylidene-3-oxatricy-
clo[6.2.1.0(2,7)]undecan-4-one
434-290-9Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
606-143-00-0abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]
avermectin B1a (purity ≥ 80 %); [2]
_ [1]
265-610-3 [2]
71751-41-2 [1]
65195-55-3 [2]
Repr. 2
Acute Tox. 2
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H300
H330
H372
(Nerven­system)
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d
H300
H330
H372
(Nerven­system)
H410
 STOT RE 1;
H372: C ≥ 5 %
STOT RE 2;
H373: 0,5 % ≤
C < 5 %
M = 10 000
 
606-144-00-6acequinocyl (ISO);
3-dodecyl-1,4-dioxo-1,4- dihydronaphthalen-2-yl acetate
57960-19-7Skin Sens. 1
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H370
(Lunge)
(Einatmung)
H373
(Blutkreis­lauf)
H400
H410
GHS07
GHS08
GHS09
Dgr
H317
H370
(Lunge)
(Einatmung)
H373
(Blutkreis­lauf)
H410
 M = 1 000 
606-145-00-1sulcotrione (ISO);
2-[2-chloro-4-(methylsulfo-
nyl)benzoyl]cyclohexane-1,3-
dione
 99105-77-8Repr. 2
STOT RE 2
 
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
H361d
H373 (Nieren)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H373 (Nieren)
H317
 
H410
 M = 1
M = 10
 
606-146-00-7tralkoxydim (ISO); 2-(N- ethoxypropanimidoyl)- 3-hydroxy-5-mesitylcyclohex-2-en-1-one87820-88-0Carc. 2
Acute Tox. 4
Aquatic Chronic 2
H351
H302
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H411
   
606-147-00-2cycloxydim (ISO); 2-(N- ethoxybutanimidoyl)-3- hydroxy-5-(tetrahydro- 2H-thiopyran-3-yl)cyclohex-2-en-1-one405-230-9101205-02-1Repr. 2H361dGHS08
Wng
H361d   
606-148-00-8Carvon (ISO);
2-Methyl-5-(prop-1-en-2-yl) cyclohex-2-en-1-on; [1]
d-Carvon; (5S)-2-Methyl-5-
(prop-1-en-2-yl)cyclohex-2-en-
1-on; [2]
l-Carvon; (5R)-2-Methyl-5-
(prop-1-en-2-yl)cyclohex-2-en-
1-on [3]
202-759-5 [1]
218-827-2 [2]
229-352-5 [3]
99-49-0 [1]
2244-16-8 [2]
6485-40-1 [3]
Skin Sens. 1H317GHS07
Wng
H317   
606-149-00-3Tembotrion (ISO); 2-{2-Chlor-
4-(methylsulfonyl)-3-[(2,2,2-
trifluorethoxy)methyl]benzoyl}
cyclohexan-1,3-dion
335104-84-2Repr. 2
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H373 (Augen, Nieren, Leber)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H373 (Augen, Nieren, Leber)
H317
H410
 M = 100
M = 10
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
606-150-00-9
Clethodim (ISO);
(5RS)-2-{(1EZ)-1-[(2E)-3-
Chlorallyloxyimino]propyl}-5-
[(2RS)-2-(ethylthio)propyl]-3-
hydroxycyclohex-2-en-1-on
99129-21-2Acute Tox. 4
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
EUH066  
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
606-151-00-4
Anthrachinon201-549-084-65-1Carc. 1BH350GHS08
Dgr
H350   
607-001-00-0formic acid ... %200-579-164-18-6Skin Corr. 1AH314GHS05
Dgr
H314 Skin Corr. 1A;
H314: C ≥ 90 %
Skin Corr. 1B;
H314: 10 % ≤ C < 90 %
Skin Irrit. 2;
H315: 2 % ≤ C < 10 %
Eye Irrit. 2; H319:
2 % ≤ C < 10 %
B
607-002-00-6acetic acid ... %200-580-764-19-7Flam. Liq. 3
Skin Corr. 1A
H226
H314
GHS02
GHS05
Dgr
H226
H314
 Skin Corr. 1A;
H314: C ≥ 90 %
Skin Corr. 1B;
H314: 25 % ≤ C < 90 %
Skin Irrit. 2;
H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319:
10 % ≤ C < 25 %
B
607-003-00-1chloroacetic acid201-178-479-11-8Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H331
H311
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H400
 STOT SE 3;
H335: C ≥ 5 %
 
607-004-00-7TCA (ISO);
trichloroacetic acid
200-927-276-03-9Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
 STOT SE 3;
H335: C ≥ 1 %
 
607-005-00-2TCA-sodium (ISO);
sodium trichloroacetate
211-479-2650-51-1STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H335
H400
H410
GHS07
GHS09
Wng
H335
H410
   
607-006-00-8oxalic acid205-634-3144-62-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
H312
H302
GHS07
Wng
H312
H302
 (*) 
607-007-00-3salts of oxalic acid with the exception of those specified elsewhere in this AnnexAcute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
 *A
607-008-00-9acetic anhydride203-564-8108-24-7Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H226
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H332
H302
H314
 Skin Corr. 1B;
H314: C ≥ 25 %
Skin Irrit. 2;
H315: 5 % ≤ C < 25 %
Eye Dam. 1;
H318: 5 % ≤ C < 25 %
Eye Irrit. 2; H319:
1% ≤ C < 5%
STOT SE 3;
H335: C ≥ 5 %
 
607-009-00-4phthalic anhydride201-607-585-44-9Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H335
H315
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H335
H315
H318
H334
H317
   
607-010-00-Xpropionic anhydride204-638-2123-62-6Skin Corr. 1BH314GHS05
Dgr
H314 Skin Corr. 1B;
H314: C ≥ 25 %
Skin Irrit. 2;
H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319:
10 % ≤ C < 25 %
 
607-011-00-5acetyl chloride200-865-675-36-5Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014  
607-012-00-0benzoyl chloride202-710-898-88-4Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H332
H312
H302
H314
H317
GHS05
GHS07
Dgr
H332
H312
H302
H314
H317
   
607-013-00-6dimethyl carbonate210-478-4616-38-6Flam. Liq. 2H225GHS02
Dgr
H225   
607-014-00-1methyl formate203-481-7107-31-3Flam. Liq. 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
H224
H332
H302
H319
H335
GHS02
GHS07
Dgr
H224
H332
H302
H319
H335
   
607-015-00-7ethyl formate203-721-0109-94-4Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
H225
H332
H302
H319
H335
GHS02
GHS07
Dgr
H225
H332
H302
H319
H335
   
607-016-00-2propyl formate; [1]
isopropyl formate [2]
203-798-0 [1]
210-901-2 [2]
110-74-7 [1]
625-55-8 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
H225
H319
H335
H336
GHS02
GHS07
Dgr
H225
H319
H335
H336
  C
607-017-00-8butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3]
209-772-5 [1]
212-105-0 [2]
208-818-1 [3]
592-84-7 [1]
762-75-4 [2]
542-55-2 [3]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335
  C
607-018-00-3isopentyl formate; [1]
2-methylbutyl formate [2]
203-769-2 [1]
252-343-2 [2]
110-45-2 [1]
35073-27-9 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335
  C
607-019-00-9methyl chloroformate201-187-379-22-1Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H225
H330
H312
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H312
H302
H314
   
607-020-00-4ethyl chloroformate208-778-5541-41-3Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H225
H330
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H302
H314
   
607-021-00-Xmethyl acetate201-185-279-20-9Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066  
607-022-00-5ethyl acetate205-500-4141-78-6Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066  
607-023-00-0vinyl acetate203-545-4108-05-4Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
H225
H351
H332
H335
GHS02
GHS08
GHS07
Dgr
H225
H351
H332
H335
  D
607-024-00-6propyl acetate; [1]
isopropyl acetate [2]
203-686-1 [1]
203-561-1 [2]
109-60-4 [1]
108-21-4 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066 C
607-025-00-1n-butyl acetate204-658-1123-86-4Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
EUH066  
607-026-00-7sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3]
203-300-1 [1]
203-745-1 [2]
208-760-7 [3]
105-46-4 [1]
110-19-0 [2]
540-88-5 [3]
Flam. Liq. 2H225GHS02
Dgr
H225EUH066 C
607-027-00-2methyl propionate209-060-4554-12-1Flam. Liq. 2
Acute Tox. 4 (*)
H225
H332
GHS02
GHS07
Dgr
H225
H332
   
607-028-00-8ethyl propionate203-291-4105-37-3Flam. Liq. 2H225GHS02
Dgr
H225